Allogene Therapeutics
Price & Volume
Stats
See more52W Range | $1.30-$4.25 |
Market Cap | $312.8M |
Shares Short | 38M |
Financials
See moreRevenue (12 Mos) | $22,000 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$192.2M |
Diluted EPS | -$1.32 |
News
See moreYahoo Finance • 24 days ago
Allogene Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update
Yahoo Finance • last month
Allogene Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update
About
CEO | Dr. David D. Chang M.D., Ph.D. |
CFO | Mr. Geoffrey M. Parker |
Address | 210 East Grand Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 226 |
